Literature DB >> 4037459

Vasopressin induced rhythmic activity in rat basilar artery.

N J Rusch, K Hermsmeyer.   

Abstract

The effects of vasopressin on membrane potential and tension were studied in isolated segments of basilar arteries from the University of Iowa colonies of normotensive inbred Kyoto-Wistar rats (WKY) and stroke-prone spontaneously hypertensive rats (SP-SHR). In the presence of vasopressin (0.01-0.3 IU/ml), basilar arteries from WKY, but not from SP-SHR, developed rhythmic contractions. These contractions were recorded in 13 of 14 WKY basilar arteries, were unaffected by pretreatment with 6-hydroxydopamine, and were characterized by 20-100 dyne oscillations in tension, occurring 1-3 cycles/min, and superimposed on the vasopressin-induced contraction (averaging 60 dynes at 0.01 IU/ml or 160 dynes at 0.3 IU/ml). However, resting membrane potentials were not different in SP-SHR vs. WKY at 37 degrees C, and both strains showed about the same (11 mV) depolarization by 0.1 IU/ml of vasopressin. The rhythmic contractions were enhanced by K+-free solution, and abolished in the presence of high K+ solution (30 mM), suggesting that active Na+-K+ transport may be involved in modulating the rhythmic activity. These findings are consistent with the hypothesis that the vasopressin-induced rhythmic contractions in WKY basilar arteries are at least partly dependent on a reduced activity of electrogenic Na+-K+ active transport in WKY as compared to SP-SHR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037459     DOI: 10.1007/bf02584247

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  13 in total

1.  Ba2+ and K+ alteration of K+ conductance in spontaneously active vascular muscle.

Authors:  K Hermsmeyer
Journal:  Am J Physiol       Date:  1976-04

2.  Localized neurogenic vasoconstriction of the basilar artery.

Authors:  J A Bevan; R D Bevan
Journal:  Stroke       Date:  1973 Sep-Oct       Impact factor: 7.914

Review 3.  Vascular smooth muscle. I. Normal structure, pathology, biochemistry, and biophysics.

Authors:  A P Somlyo; A V Somlyo
Journal:  Pharmacol Rev       Date:  1968-12       Impact factor: 25.468

4.  Autonomous activity in the human basilar artery: relationship to cerebral vascular spasm.

Authors:  C A Miller; D Yashon; G Locke; W E Hunt
Journal:  Neurology       Date:  1971-12       Impact factor: 9.910

5.  A method for continuous monitoring of pial vessel diameter changes and its value for dynamic studies of the regulation for cerebral circulation. A preliminary report.

Authors:  L Aver
Journal:  Pflugers Arch       Date:  1978-02-22       Impact factor: 3.657

6.  Structural and functional changes in cerebral arteries from spontaneously hypertensive rats.

Authors:  R J Winquist; D F Bohr
Journal:  Hypertension       Date:  1983 May-Jun       Impact factor: 10.190

7.  Comparison of electrical properties of middle cerebral and mesenteric artery in cat.

Authors:  D R Harder
Journal:  Am J Physiol       Date:  1980-07

8.  Electrogenesis of increased norepinephrine sensitivity of arterial vascular muscle in hypertension.

Authors:  K Hermsmeyer
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

9.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

10.  Membrane ATPase mechanism of K+-return relaxation in arterial muscles of stroke-prone SHR and WKY.

Authors:  K Hermsmeyer; D Harder
Journal:  Am J Physiol       Date:  1986-04
View more
  2 in total

1.  Central angiotensin II stimulates arteriolar vasomotion in conscious hamsters.

Authors:  R Rettig; J U Meyer; R Gerstberger; M P Printz; M Intaglietta
Journal:  J Comp Physiol B       Date:  1989       Impact factor: 2.200

2.  Aptamer based surface enhanced Raman scattering detection of vasopressin using multilayer nanotube arrays.

Authors:  Yun Suk Huh; David Erickson
Journal:  Biosens Bioelectron       Date:  2009-10-07       Impact factor: 10.618

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.